Cytomos

To add a bio or update company history, please click update information.

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

19 Nov 2024

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

Cytomos builds scalable cell analysis technology that measures intrinsic cellular properties in real time, helping biopharma companies accelerate drug discovery and manufacturing decisions.

Cytomos

Life Sciences
Edinburgh, United Kingdom
£5m
cytomos.com
Update Information

More venture news

Healome Therapeutics
7 Jul 2026
Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease
SeedLife Sciences
Revolver Therapeutics
6 Jul 2026
Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
EquityLife Sciences
RQ Bio
25 Jun 2026
RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences

Cytomos

News from Cytomos

Cytomos secures £5m led by Archangels to scale up production of cell-analysis technology

More venture news

Healome Therapeutics raises £2m to advance eye-drop matrix technology treating dry eye and ocular surface disease

Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins

RQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza